Cardiol Therapeutics (CRDL) Stock Chart & Stock Price History C$1.49 +0.04 (+2.76%) As of 10/3/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Cardiol Therapeutics Stock Price Performance The Cardiol Therapeutics (CRDL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 43.98%, with a year-to-date return of -19.46%. In the past month, the stock has decreased 3.25%, reflecting recent market activity. As of the latest close, Cardiol Therapeutics traded at C$1.49 with a market cap of C$124.76 million and volume of 108,304 shares. Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.67%1 Month Performance-3.25%3 Month Performance-27.32%Year-To-Date Performance-19.46%1 Year Performance-43.98% CRDL Stock Chart for Monday, October, 6, 2025 CRDL Chart by TradingView Cardiol Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025C$1.45C$1.49+2.76%C$1.50C$1.45108,304 shsC$124.76 million10/02/2025C$1.50C$1.45-3.33%C$1.51C$1.45137,765 shsC$121.41 million10/01/2025C$1.51C$1.50-0.66%C$1.52C$1.47147,148 shsC$125.59 million09/30/2025C$1.58C$1.51-4.43%C$1.58C$1.46166,336 shsC$126.43 million09/29/2025C$1.51C$1.58+4.64%C$1.62C$1.51243,790 shsC$126.43 million09/26/2025C$1.53C$1.51-1.31%C$1.54C$1.49143,950 shsC$126.43 million09/25/2025C$1.51C$1.53+1.32%C$1.54C$1.4994,368 shsC$128.11 million09/24/2025C$1.54C$1.51-1.95%C$1.58C$1.50169,622 shsC$126.43 million09/23/2025C$1.54C$1.54C$1.57C$1.48136,033 shsC$128.94 million09/22/2025C$1.55C$1.54-0.65%C$1.57C$1.5183,334 shsC$128.94 million Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025C$1.51C$1.55+2.65%C$1.57C$1.48412,503 shsC$129.78 million09/18/2025C$1.50C$1.51+0.67%C$1.57C$1.47154,903 shsC$126.43 million09/17/2025C$1.47C$1.50+2.04%C$1.51C$1.4657,775 shsC$125.59 million09/16/2025C$1.49C$1.47-1.34%C$1.49C$1.4669,219 shsC$123.08 million09/15/2025C$1.51C$1.49-1.32%C$1.53C$1.4864,885 shsC$124.76 million09/12/2025C$1.48C$1.51+2.03%C$1.51C$1.4651,135 shsC$126.43 million09/11/2025C$1.50C$1.48-1.33%C$1.53C$1.4671,821 shsC$123.92 million09/10/2025C$1.45C$1.50+3.45%C$1.57C$1.44159,808 shsC$125.59 million09/09/2025C$1.47C$1.45-1.36%C$1.50C$1.43116,712 shsC$121.41 million09/08/2025C$1.54C$1.47-4.55%C$1.53C$1.4564,008 shsC$123.08 million09/05/2025C$1.53C$1.54+0.65%C$1.56C$1.46138,680 shsC$128.94 million Related Companies Fennec Pharmaceuticals Stock Price Chart Aimia Stock Price Chart Graphite One Stock Price Chart Canadian Gold Stock Price Chart Medicenna Therapeutics Stock Price Chart EQ Stock Price Chart CI Canadian Convertible Bond ETF Common Stock Price Chart Relevant Gold Stock Price Chart BioRem Stock Price Chart Niobay Metals Stock Price Chart Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CRDL) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
